Stenting of Complex Lesions
“Not all drug-eluting stents are created equal.”
Sripal Bangalore, MD, noting positive XIENCE outcomes
at TCT 2016
Increasingly Complex Patients Now Treated with PCI
Complex lesions and increasingly complex cases compose an ever-growing segment of the patient population.
Many complex patients are now able to benefit from minimally invasive procedures like percutaneous coronary intervention (PCI), whereas in previous years stenting of complex lesions may not have been an option. Using XIENCE in many complex patients is associated with low rates of stent thrombosis. Consequently, stenting for complex lesions may in fact expand in the future.
XIENCE for Complex Patients
XIENCE, the world’s leading drug-eluting stent (DES), is considered by industry experts to be the gold standard. It is increasingly used—and evaluated via clinical trials—in complex patients:
“The benefit of [XIENCE] occurred immediately after implantation and . . . also at long-term follow-up beyond 2 years.”
— Manel Sabaté, MD, on the EXAMINATION trial's lower event rates for XIENCE versus bare metal stents in STEMI patients6
XIENCE Complex Patient Data: Consistently Low Stent Thrombosis
Results from a number of multicenter, randomized trials reveal the efficacy and safety of XIENCE, particularly regarding low stent thrombosis rates.